With March in the rear view window, the Investing News Network (INN) presents a closer look at the biggest stories for the marijuana investing market last month.


Two critical cannabis markets — the US and Canada — held the attention of investors. As Florida lifted a ban on smokable products, companies were able to start selling the popular products, boosting predictions for the performance of this state.

In Canada, as Ontario prepared for the opening of its retail market, further deals were signed between publicly traded marijuana companies and some of the 25 lottery winners looking to open shops.

Cannabis accessory developer and retail operator High Tide (CSE:HITI,OTC Pink:HTDEF) signed its third store agreement in Ontario, securing a spot in Toronto.

“As the realities of a compressed schedule and complex project became clear, the third winner realized that they would benefit from our help,” Raj Grover, president and CEO of High Tide, said in a release.

Canopy Growth (NYSE:CGC,TSX:WEED) secured a second branding deal for a store in Ontario, this time by lending the Tokyo Smoke brand to a location near the popular Yonge-Dundas Square in Toronto.

The Tokyo Smoke shop completed its public notice period on Tuesday (April 2). Bruce Linton, co-CEO of Canopy, previously told INN he hopes the brands attract consumers; for Canopy, the focus is on keeping cannabis supply up for the province.

Meanwhile, Canadian producer HEXO (NYSEAMERICAN:HEXO,TSX:HEXO) announced a plan to purchase Newstrike Brands (TSXV:HIP,OTC Pink:NWKRF) in a deal worth C$275.9 million.

As a result of the acquisition, HEXO will become more established with retailer Inner Spirit Holdings (CSE:ISH) due to Newstrike’s partnership with Inner Spirit. The stores from the public retailer, dubbed Spiritleaf, carry a special hub dedicated to the Up Cannabis brand from Newstrike. The stores include images from Canadian rock band The Tragically Hip, which has invested in Newstrike.

“We welcome and look forward to working with the HEXO team and building on the foundation that has been put in place,” Darren Bondar, president and CEO of Inner Spirit, told INN in an email statement.

Florida boosts performance of MSOs

The cannabis market in Florida was in the spotlight as smokable products were finally allowed to be sold in the state. The sunshine state was also in focus thanks to developments from some multi-state operators (MSOs) active in the market.

Trulieve Cannabis (CSE:TRUL,OTC Pink:TCNNF) took advantage of the lift on smokable items to inform shareholders that these products will be available in its stores.

“Offering these whole flower products to our patients in their purest, most effective form is something we — and patients — have been looking forward to since we opened the doors of the state’s first dispensary,” Kim Rivers, CEO of Trulieve, said in a press release.

During a fiscal Q4 2018 results conference call, Joseph Lusardi, CEO of Curaleaf (CSE:CURA,OTCQX:CURLF), said he is expecting the market to double thanks to this policy change. He indicated that the company also expects to see some form of policy around edibles sometime this year.

Also last month, fellow MSO Cresco Labs (CSE:CL,OTCQX:CRLBF) confirmed the purchase of a stake in the promising Florida market. The company will pay US$120 million for local company VidaCann, which will grant it seven active dispensaries with more on the way.

Watch the video above for more on what happened during the month of March.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Inner Spirit Holdings and High Tide are clients of the Investing News Network. This article is not paid-for content.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less